1-2 of 2
Arnon P. Kater
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

Open Access
McKensie A. Collins, In-Young Jung, Ziran Zhao, Kimberly Apodaca, Weimin Kong, Stefan Lundh, Joseph A. Fraietta, Arnon P. Kater, Clare Sun, Adrian Wiestner, J. Joseph Melenhorst
Journal: Cancer Research Communications
Cancer Research Communications (2022) 2 (9): 1089–1103.
https://doi.org/10.1158/2767-9764.CRC-22-0200
Published: 30 September 2022
View articletitled, Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
Open the PDF for Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL in another window
Includes: Supplementary data
Journal Articles

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas

Open Access
Anne W.J. Martens, Joanne M. Rietveld, Renate de Boer, Fleur S. Peters, An Ngo, Lotte W.H.G. van Mil, Koen de Heer, Marcel Spaargaren, Christie P.M. Verkleij, Niels W.C.J. van de Donk, Homer C. Adams, III, Eric Eldering, Carel J.M. van Noesel, Raluca Verona, Arnon P. Kater
Journal: Cancer Research Communications
Cancer Research Communications (2022) 2 (5): 330–341.
https://doi.org/10.1158/2767-9764.CRC-22-0083
Published: 09 May 2022
View articletitled, Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
Open the PDF for Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas in another window
Includes: Supplementary data